CASE CHALLENGE: ICH IN A DOAC-ANTICOAGULATED PATIENT

1b) #Physicians #Nurses #Pharmacists #physicianassociate #NPs earn 0.5h CE/#CME from @academiccme for following this 🧵 pic.twitter.com/WTdiTjcABR— cardio-met (@cardiomet_CE) October 18, 2022 3) And we start with a case . . . 79♂️ with HTN, Afib on #apixaban,...

Risk-adjusted Duration of Anticoagulation for VTE

1b) BTW, Dr. Arya is Theme Leader for #VTE at the upcoming #ISTH2022 congress in London that kicks off this weekend. It will be the most important international meeting of the year in the field of #thrombosis and #hemostasis and we are proud to have our faculty among...

Cancer-Associated VTE

1) Welcome to a new #accredited #tweetorial on a🗝️ topic in #cancer care & #vascular medicine: #VTE (#DVT and #PE). Cancer patients are at⬆️risk from their disease, their comorbidities, & often from their treatment. It's a sticky wicket &...